Vor Biopharma Inc

NASDAQ:VOR  
4.22
+0.33 (+8.48%)
Earnings Announcements

Vor Bio Reports First Quarter 2022 Financial Results

Published: 05/12/2022 20:21 GMT
Vor Biopharma Inc (VOR) - Vor Bio Reports First Quarter 2022 Financial Results and Provides Company Update.
Vor Biopharma Inc - Qtrly Loss per Share $0.61.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.68

More details on our Analysts Page.